RTN4R and neoplasm: Another important Phase I clinical study, performed on 31 patients with advanced solid tumors, showed that the anti-vascular activity of NGR-hTNF was inversely correlated to the tumor dimension, probably because of the presence of a less-mature neovasculature in small lesions [46].